Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Ph D Position In Medical Science How Do Glp 1 Analogues Alleviate Obesity?, Sahlgrenska academy, Sweden, 13 days ago
Job posted by Sahlgrenska academy (19/04/2016 18.54) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Rese...
University Of Cambridge Med Immune Ph D, Clinical Academic Training Office, United Kingdom, 20 days ago
Job posted by Clinical Academic Training Office (12/04/2016 16.29) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and...
Ph D Studentship In Neuroscience (Lipidomics), The University of Queensland, Australia, 26 days ago
Apply now Job no:498832 Area:Queensland Brain Institute Salary (FTE):APA Scholarship NON-BANDED ($26,288.00 - $26,288.00) Work type:Full Time - Scholarship Location: St Lucia Queensland Brain Inst...
Ph D Scholarship In Vascular Health In Indigenous Australians, University of Sydney, Australia, 1 day ago
Funding Body: Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders – Charles Perkins Centre, The University of Sydney Title: PhD Scholarship in Vascular Health in Indigenous Austra...
Ph D Student Mucosal Immunology, Job AMC Medical Research, Netherlands, 30 days ago
Job posted by universitypositions (01/04/2016 15.39) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Rese...
Ph D Position In Physiology, Uppsala universitet, Sweden, 6 days ago
Job posted by Uppsala Universitet via MyNetwork (26/04/2016 03.30) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and...